Founded in 2022, SYNLIFE® is the world's only company capable of directly utilizing carbon dioxide to synthesize polylactic acid (PLA) in a single-step process within living cells. SYNLIFE® focuses on efficiently developing bio-based products—including high-performance materials—through advanced synthetic biology. We are committed to helping humanity break free from fossil fuel dependence and embrace a high-quality, green, and sustainable production and lifestyle.
Percentage of products made from renewable materials.
China and PCT-Granted Patents.
Annual production capacity of bio-based materials.
Square Meter R&D Center.
R&D Centers
Business Platforms
Production Base
SYNLIFE® Bio-Based Stationery
Inspired by Nature, Pen to Paper
SYNLIFE® Fashion Apparel
Fashion from the Source
ZeRoll® Food Wrap
Next-Generation “Zero-Plastic” Biodegradable Food Wrap
Biowatol® Bio-Based Moisturizing Ingredient
Small molecules, more skin-friendly
Yogtic® High-Performance Bio-Based Resin
Let Nature Surpass Nature
In August 2025, the company's self-built thousand-ton-scale flexible synthetic biology production line in Rugao commenced trial operations and entered full production.
In June 2025, the bio-based fountain pen co-developed with Shanghai Hero Group made its debut launch. The “Wildflowers in the Fields” series was nominated as a recommended souvenir gift by Minhang District, Shanghai, gradually expanding commercial applications for bio-based materials.
May 2025: The company and Mingzhuang Environmental Protection established a strategic partnership at the China Beauty Expo to jointly expand sustainable packaging applications for bio-based materials. The company also completed tens of millions of yuan in Pre-A+ round financing, exclusively invested by Shanghai Guotou Futeng Capital.
April 2025: The company partnered with the Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences to develop bulk bio-based monomer products using methanol as feedstock, advancing the industrialization of “one-carbon bio-manufacturing.”
October 2024: Sipeng Technology completed a Pre-A round financing of nearly 100 million yuan, led by SDIC Innovation & Investment with participation from Rugao Sci-Tech Investment, accelerating the company's industrialization and commercialization efforts.
September 2024: The Eco series of bio-based ballpoint pens, jointly developed with Japan's Platinum, debuted at the China International Industry Fair, accelerating commercial expansion.
May 2024: The company formally signed an investment agreement with Rugao City, Jiangsu Province, launching its self-built flexible synthetic biology production line project with an annual capacity of 1,000 tons.
April 2024: The founder-led Carbon Negative Synthetic Biology (CNSB) project was officially launched in Singapore, receiving US$13 million in support from the Singaporean government.
In December 2023, the company formally established a joint venture with Angel Yeast to advance the industrialization and commercial promotion of bio-manufactured products such as BDO.
In November 2023, the company entered into a strategic partnership with Quanli Bio, a renowned cosmetics OEM enterprise, to progressively initiate commercialization.
In June 2023, the BDO product developed through the company's collaboration with Angel Yeast completed pilot-scale validation.
November 2022: Established a strategic partnership with Angel Yeast, the world's second-largest yeast fermentation enterprise.
September 2022: Sipeng Technology completed tens of millions of yuan in angel round financing, led by Bencao Capital with participation from Zhongke Chuangxing.
May 2022: Shanghai Sipeng Technology Co., Ltd. was registered and established during Shanghai's pandemic risk control period.
